What You Should Know
- January AI has transitioned its science-validated "virtual glucose monitor" technology into a suite of Enterprise APIs, enabling B2B partners to embed AI-powered food recognition and glucose prediction into their own platforms.
- This move allows health systems and longevity companies to turn underutilized lifestyle signals—like photos and wearable data—into structured, metabolic insights at scale.
The "Context Gap": Why Lifestyle Data Often
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
The Digital Insider: Securing Agentic AI in the 2026 Healthcare Landscape
Hospitals have thrown their doors open to a new kind of technology that can think, act and make changes faster than any human. And with healthcare generating more than 30% of the world’s data, the industry has, for better or worse, become the ultimate proving ground for AI, from all of the good it can support to all of the threats that it amplifies.
AI is being woven into diagnostics, scheduling, documentation and the overarching integration and interoperability plans that make healthcare
Read More
The EEG as a ‘Vital Sign’: Ceribell’s AI Pivot to In-Hospital Stroke Detection
What You Should Know:
- Ceribell’s LVO Stroke Breakthrough In January 2026, the FDA granted Breakthrough Device Designation to Ceribell for its LVO (Large Vessel Occlusion) stroke monitor.
- This first-in-class tool applies an AI algorithm to portable EEG hardware to detect in-hospital strokes—which account for 17% of all strokes and have a mortality rate 3x higher than community-onset strokes. By providing continuous bedside monitoring, it aims to eliminate the "detection gap"
Read More
AMA’s Strategic Push for Permanent Medicare Telehealth Reform
What You Should Know
- The AMA is urging Congress to pass permanent authorization of Medicare telehealth services before the current waiver expires on January 30, 2026.
- This advocacy follows a "tumultuous" 2025 in which a 43-day government shutdown caused a 24% national drop in fee-for-service telemedicine visits, demonstrating the extreme sensitivity of patient access to legislative lapses.
The Economic Battle: Challenging CBO Scoring
The crux of the AMA’s issue brief is a
Read More
Abbott Debuts GenAI ‘Libre Assist’ to Tackle Mealtime Decision Fatigue
What You Should Know:
- Launched at CES 2026, Abbott’s Libre Assist,is a generative AI feature within the Libre app that predicts glucose impact before consumption.
- Using a color-coded rating (Green/Yellow/Orange), it acts as a "digital twin" for nutrition. The system then "closes the loop" by reconciling its prediction against real-world data from the Libre 3 Plus sensor, providing a medically validated feedback loop.
The Technical Architecture
Libre Assist can be
Read More
The $149 Disruptor: GoodRx WeightWatchers, LifeMD Aggressively Scale Access to FDA-Approved Wegovy Pill
What You Should Know:
- The healthcare landscape is witnessing a seismic shift in obesity care as GoodRx, WeightWatchers LifeMD launch the newly FDA-approved Wegovy pill (oral semaglutide) with a transparent cash-pay price of $149 per month.
- By combining 16.6% mean weight loss efficacy with a vast retail and telehealth infrastructure, this rollout effectively removes the twin barriers of injection hesitancy and opaque "middleman" pricing.
Breaking the Injection Barrier: The
Read More
7 Ways AI Will Actually Transform Behavioral Health in 2026
The integration of AI into behavioral health has moved from experiment to expectation. The industry is rapidly finding its footing, moving past initial hype and learning from cautionary tales to focus on real-world impact. While the debate around patient-facing AI continues, the true transformation is happening in the trenches. Let's be clear: AI isn't what many think it is. Here are the seven key trends that will define mental healthcare's AI transformation in 2026.
1. AI Isn't Just Chatbots
Read More
Unlocking Real-World Evidence: 5 Questions to Ask Before Trusting AI-Curated RWD
In today’s pharmaceutical industry, real-world evidence (RWE) offers significant potential across all phases of the product life cycle, from trial design to product launch, from pricing and competitive reviews to evaluating the effects of switching medications.
As RWE becomes a key tool for life sciences organizations to shape clinical trial strategies, advance treatment development, and meet regulatory requirements, the quality of the underlying data and trust in how it was generated is
Read More
Combatting Patient Aggression: How Vocal Biomarkers Can Protect Hospital Staff in 2026
Patient aggression in the hospital is a growing problem. Among nurses and other staff, violent or abusive behaviors have been linked to burnout and PTSD — two of the many reasons nurses have left the medical profession in recent years by the thousands. Preventing aggressive behavior before it can begin is perhaps the most effective, and elusive, strategy for reversing the trend.
Here’s a closer look at the problem
Read More
Retail Pharmacy 2026 Forecast: From “Hard Truths” to AI-Driven Innovation
2025 has been a year of hard truths for retail pharmacy.
Persistent reimbursement pressures, escalating fees, workforce shortages and policy whiplash have forced many operators to rethink how they serve patients and sustain their businesses. Expanding into clinical services and stepping into the role of frontline healthcare providers is becoming an expectation, not an option. Direct-to-payer contracting is no longer experimental.
But perhaps the most palpable change for
Read More
